The three biggest growth opportunities we see for Northrop are the Sentinel, the further militarization of space, and the continued development and eventual manufacture of the B-21 bomber. While ...
Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.